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A decade of malaria during pregnancy in Brazil: what has been done 
concerning prevention and management
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In Brazil, malaria remains a disease of major epidemiological importance because of the high number of cases 
in the Amazonian Region. Plasmodium spp infections during pregnancy are a significant public health problem with 
substantial risks for the pregnant woman, the foetus and the newborn child. In Brazil, the control of malaria dur-
ing pregnancy is primarily achieved by prompt and effective treatment of the acute episodes. Thus, to assure rapid 
diagnosis and treatment for pregnant women with malaria, one of the recommended strategy for low transmission 
areas by World Health Organization and as part of a strategy by the Ministry of Health, the National Malaria Con-
trol Program has focused on integrative measures with woman and reproductive health. Here, we discuss the ap-
proach for the prevention and management of malaria during pregnancy in Brazil over the last 10 years (2003-2012) 
using morbidity data from Malaria Health Information System. Improving the efficiency and quality of healthcare 
and education and the consolidation of prevention programmes will be challenges in the control of malaria during 
pregnancy in the next decade.
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Approximately 125 million pregnant women world-
wide are exposed to the risks of malaria in pregnancy 
(MiP) each year, resulting in 200,000 infant deaths 
(Steketee et al. 2001, Dellicour et al. 2010). In malaria 
hyper and holoendemic regions, pregnant women to-
gether with children less than five years old are the most 
susceptible individuals to Plasmodium spp infections. 
The symptoms and complications of MiP vary accord-
ing to the transmission intensity and level of acquired 
immunity. Overall, MiP can result in stillbirth, sponta-
neous abortion, low birth weight (birth weight < 2.5 kg) 
and neonatal and maternal death. Pregnant women have 
an overall decrease in resistance to infections and, when 
living in areas of low or unstable malaria transmission, 
such as some areas of Brazilian Amazon may have little 
or no immunity to malaria. They present a two-three-
fold higher risk of developing severe effects compared 
to their non-pregnant peers. Interestingly, the disease 
severity is normally increased in first and second preg-
nancies, suggesting that robust protective immunologi-
cal mechanisms are induced after several pregnancies 
(Brabin et al. 2004). In addition, there appears to be an 
increased susceptibility to Plasmodium falciparum in-
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fection or disease even in areas where malaria by other 
plasmodial species are more prevalent (Martínez-Es-
pinosa et al. 2004, Parekh et al. 2007).
In Brazil, malaria transmission occurs almost exclu-
sively in the Amazon Region (99.6% of cases), where 
Plasmodium vivax and P. falciparum coexist. P. vivax 
is the most important malaria species associated with 
infection, since it accounts for around 85% of the reg-
istered cases, contrasting with the situation in most of 
Africa and in Asia, where MiP is typically caused by P. 
falciparum. In the last decade, Brazil has successfully 
reduced both malaria morbidity and mortality. The Na-
tional Malaria Control Program (NMCP) is responsible 
for funding disease control measures and formulates the 
major policies that are followed by all of the states and 
municipalities. However, funding is managed in a de-
centralised manner. The total number of malaria cases 
reported in Brazil has dropped almost two-fold, from 
635,646 cases in 1999 to approximately 235,000 cases in 
2012 (Figure). Data subject to revision showed approxi-
mately 178,000 cases in 2013. This significant reduction 
was observed in all groups at risk, including pregnant 
women. Nevertheless, in Brazil, the pathogenic mecha-
nisms involved in MiP are still puzzling, which makes 
its real burden unknown and indicates the urgency of 
intense investigation (Costa et al. 2012).
In 2006, the NMCP published a technical note with 
some recommendations for the treatment and care of 
pregnant women in endemic areas. According to it, all 
women undergoing prenatal care should be tested for 
malaria at every antenatal care (ANC) visit to ensure 
faster diagnosis and treatment and it was emphasised 
that healthcare professionals should ensure compliance 
with treatment. Moreover, as the use of insecticide-
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treated nets (ITNs) demonstrated a significant impact 
on decreasing the exposure to infective mosquito bites 
(Gutman & Kachur 2010), the NMCP began the free dis-
tribution of ITNs to municipalities with a greater malaria 
burden in 2010. The rationale was to ensure coverage of 
at least 80% of these areas, thereby reducing transmis-
sion and improving individual protection for the entire 
population of these areas, including pregnant women 
and children less than five years of age.
Another strong element of the malaria prevention 
and control strategy is based on a robust, locally avail-
able and up-to-date information system, allowing the 
identification of essential epidemiological variables. In 
Brazil, the Epidemiological Surveillance Information 
System (SIVEP)-Malaria is used for the notification of 
every malaria case diagnosed (de Almeida et al. 2010). 
Consequently, every diagnosed case is properly notified 
and patients are treated promptly.
Pregnant women must receive prompt treatment with 
effective antimalarial medication accompanied by the rec-
ommended supportive care. Close collaboration between 
malaria control and reproductive health programmes is 
needed to facilitate the development of systematic man-
agement protocols and drug supply strategies. In 2014, 
the so-called “Stork Network” will reinforce NMCP rec-
ommendations and emphasise that the malaria slide test 
in endemic region should be performed during the estab-
lished standard six or more prenatal visits. In fact, the 
number of consultations during prenatal care is directly 
related to the best indicators of maternal and child health. 
However, executing this strategy will be a challenging 
task due to the difficulty of implementing a system capa-
ble of assuring an adequate number of visits.
Observational data showed that the proportion of 
live births with seven or more prenatal consultations in-
creased from 46.2% in 2000 to 58.8% in 2009. In gener-
al, there have been improvements in healthcare for preg-
nant women, but it should be noted that this indicator 
hides important inter-regional differences in Brazil. For 
instance, in 2010 in the southern region of Brazil, 75.3% 
of live births followed at least seven prenatal visits, 
whereas this proportion dropped to 36.8% for the states 
in the northern region. Moreover, differences were also 
observed regarding states from the same region. For ex-
ample, in the northern region, this proportion was 49% 
in the state of Rondônia, in contrast to 31.1% in the state 
of Acre (dssbr.org/site/). These observations clearly indi-
cate profound regional discrepancies.
Studies of MiP have been more frequent and are sup-
ported by the Ministry of Health in Brazil because aware-
ness of the deleterious effects of this disease on the moth-
er and foetus has been placed on the agenda of countries 
of low and moderate endemicity. Preventive programmes 
delivered through ANC frequently face challenges due 
to late ANC attendance and non-compliance, which can 
limit the impact of interventions during pregnancy and 
give rise to a null result. Therefore, at the local level in 
Brazil, there is a need to integrate malaria control and 
reproductive health programmes to facilitate malaria di-
agnosis and treatment for pregnant women, preferably at 
the same site. The Family Health Program should moni-
tor compliance to treatment, for example, through daily 
visits by healthcare workers. The use of ITNs should be 
monitored to ensure that pregnant women use bed nets 
throughout the gestational period. Healthcare workers 
should be trained to provide these recommendations to 
pregnant women during their ANC visits and during 
home visits of Family Health Program healthcare work-
ers (Ndyomugyenyi et al. 2011). In addition to monitoring 
quinine efficacy, it is very important to pay special atten-
tion to the pharmacovigilance of antimalarial drugs used 
during pregnancy, aiming for improvements in treatment 
for P. falciparum during the first trimester.
In conclusion, although pregnant and non-pregnant 
women present the same patterns regarding the number of 
cases according to SIVEP, the risks of disease severity are 
still a threat for pregnant women with malaria. Thus, the 
NMCP needs to take special measures to protect pregnant 
women from malaria infection and from the deleterious 
effects to the mother and her baby, taking into consid-
eration their specific and local circumstances. We lastly 
believe that community-based awareness and educational 
programmes are essential to educate women about the 
risks associated with malaria during pregnancy.
Number of positive slides by species, non-pregnant and pregnant women. Source: Epidemiological Surveillance Information System-Malaria.
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